Literature DB >> 10341260

The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice.

R J Ralph1, G B Varty, M A Kelly, Y M Wang, M G Caron, M Rubinstein, D K Grandy, M J Low, M A Geyer.   

Abstract

Brain dopamine (DA) systems are involved in the modulation of the sensorimotor gating phenomenon known as prepulse inhibition (PPI). The class of D2-like receptors, including the D2, D3, and D4 receptor subtypes, have all been implicated in the control of PPI via studies of DA agonists and antagonists in rats. Nevertheless, the functional relevance of each receptor subtype remains unclear because these ligands are not specific. To determine the relevance of each receptor subtype, we used genetically altered strains of "knock-out" mice lacking the DA D2, D3, or D4 receptors. We tested the effects of each knock-out on both the phenotypic expression of PPI and the disruption of PPI produced by the indirect DA agonist d-amphetamine (AMPH). No phenotypic differences in PPI were observed at baseline. AMPH significantly disrupted PPI in the D2 (+/+) mice but had no effect in the D2 (-/-) mice. After AMPH treatment, both DA D3 and D4 receptor (+/+) and (-/-) mice had significant disruptions in PPI. These findings indicate that the AMPH-induced disruption of PPI is mediated via the DA D2 receptor and not the D3 or D4 receptor subtypes. Uncovering the neural mechanisms involved in PPI will further our understanding of the substrates of sensorimotor gating and could lead to better therapeutics to treat gating disorders, such as schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341260      PMCID: PMC6782596     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine.

Authors:  M Rubinstein; T J Phillips; J R Bunzow; T L Falzone; G Dziewczapolski; G Zhang; Y Fang; J L Larson; J A McDougall; J A Chester; C Saez; T A Pugsley; O Gershanik; M J Low; D K Grandy
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

2.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

Review 3.  Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.

Authors:  L J Bristow; M S Kramer; J Kulagowski; S Patel; C I Ragan; G R Seabrook
Journal:  Trends Pharmacol Sci       Date:  1997-06       Impact factor: 14.819

4.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

Review 5.  Dopamine receptor pharmacology.

Authors:  P Seeman; H H Van Tol
Journal:  Trends Pharmacol Sci       Date:  1994-07       Impact factor: 14.819

6.  Gating and habituation of the startle reflex in schizophrenic patients.

Authors:  D L Braff; C Grillon; M A Geyer
Journal:  Arch Gen Psychiatry       Date:  1992-03

7.  Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Authors:  M Xu; T E Koeltzow; G T Santiago; R Moratalla; D C Cooper; X T Hu; N M White; A M Graybiel; F J White; S Tonegawa
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

8.  Inbred strain differences in prepulse inhibition of the mouse startle response.

Authors:  R Paylor; J N Crawley
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

9.  Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats.

Authors:  C Johansson; D M Jackson; J Zhang; L Svensson
Journal:  Pharmacol Biochem Behav       Date:  1995-12       Impact factor: 3.533

10.  Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia.

Authors:  N R Swerdlow; M A Geyer
Journal:  Pharmacol Biochem Behav       Date:  1993-03       Impact factor: 3.533

View more
  52 in total

1.  Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice.

Authors:  Maarten van den Buuse; Margaret Morris; Carolina Chavez; Sally Martin; JianHong Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 2.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 3.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

4.  Gαz regulates BDNF-induction of axon growth in cortical neurons.

Authors:  Rainbo Hultman; Udhaya Kumari; Nadine Michel; Patrick J Casey
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

5.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

6.  Disruption of prepulse inhibition of the startle reflex by the preferential D(3) agonist ropinirole in healthy males.

Authors:  Stella G Giakoumaki; Panos Roussos; Sophia Frangou; Panos Bitsios
Journal:  Psychopharmacology (Berl)       Date:  2007-06-20       Impact factor: 4.530

7.  Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats.

Authors:  Jorge D Brioni; Robert B Moreland; Marlon Cowart; Gin C Hsieh; Andrew O Stewart; Petter Hedlund; Diana L Donnelly-Roberts; Masaki Nakane; James J Lynch; Teodozyi Kolasa; James S Polakowski; Mark A Osinski; Kennan Marsh; Karl-Erik Andersson; James P Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

Review 8.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

9.  Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.

Authors:  Tai-Xiang Xu; Tatyana D Sotnikova; Chengyu Liang; Jingping Zhang; Jae U Jung; Roger D Spealman; Raul R Gainetdinov; Wei-Dong Yao
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

Review 10.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.